Patent · US Active

Methods of selecting and isolating cancer stem cells

US10509036B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2017
Grant dateDec 17, 2019
Priority date
Expiry dateMay 30, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/582
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided herein are methods for selecting/identifying and/or isolating cancer stem cells from a biological sample or a cell culture sample using a fluorescent glucose analog. Also provided herein are methods for selecting/identifying and/or isolating leukemia stem cells and subpopulations thereof. The present invention is based, in part, on the discovery that cancer stem cells can be selected/identified based upon a lower level of fluorescence of the fluorescent glucose analog compared to non-cancer stem cells and that specific genes are differentially expressed in leukemia stem cells compared to non-leukemia stem cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.